Antitrust Antitrust

Gilead, Teva settle with some plaintiffs as US trial starts in HIV drug case

By Michael Acton
  • 25 May 2023 17:21
  • 25 May 2023 17:21
Gilead and Teva have reached settlements with some plaintiffs suing them over an allegedly illegal pay-for-delay agreement for HIV drugs, the California federal judge in the case confirmed today as a trial began.

Gilead has reached a resolution with direct purchasers and retailers, while Teva has reached a settlement with retailers. US District

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Michael Acton

Senior Correspondent

Michael is a senior correspondent for MLex in San Francisco, where he moved in 2020 after working in our Brussels bureau. Before joining MLex, he reported on EU politics as the Financial Times’ Nico Colchester Fellow in Brussels. Michael has a degree in International Relations and Politics from the University of Cambridge, and a degree in History and French from University College London and Paris IV Sorbonne.

Discover MLex

Stay on top of global regulatory developments

Latest News